EP3328399
MODIFIED CELLS AND METHODS OF THERAPY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.7.2016EP published:
27.12.2023EP application number:
16833645.1
EPO information:
European Patent Register
Max expiry date:
28.7.2036
Title in English:
MODIFIED CELLS AND METHODS OF THERAPYLanguage of the patent:
English
Timeline
Today
29.7.2016EP application
27.12.2023EP Publication
Owner
Name:
Regents of the University of MinnesotaAddress:
600 McNamara Alumni Center 200 Oak Street SE, Minneapolis, MN 55455-2020, US
Name:
Intima Bioscience, Inc.Address:
3 Columbus Circle, New York, New York 10019, US
Name:
The United States of America, as represented by the Secretary, Department of Health and Human ServicesAddress:
6011 Executive Boulevard, Suite 325, MSC 7660, Bethesda, MD 20892-7660, US
Inventor
Name:
MORIARITY, BrandenAddress:
Shoreview, Minnesota 55126, US
Name:
WEBBER, BeauAddress:
Coon Rapids Minnesota 55448, US
Name:
MCIVOR, Scott, R.Address:
St. Louis Park Minnesota 55416, US
Name:
LARGAESPADA, DavidAddress:
Mounds View, Minnesota 55112, US
Name:
CHOUDHRY, ModassirAddress:
New York, New York 10019, US
Name:
ROSENBERG, Steven A.Address:
Potomac, Maryland 20854, US
Name:
RESTIFO, Nicholas P.Address:
Chevy Chase, 20815, US
Name:
PALMER, Douglas C.Address:
North Bethesda, MD 20852, US
Priority
Number:
201562199905 PDate:
31.7.2015Country:
US
Number:
201562232983 PDate:
25.9.2015Country:
US
Number:
201662286206 PDate:
22.1.2016Country:
US
Number:
201662295670 PDate:
16.2.2016Country:
US
Number:
201662330464 PDate:
2.5.2016Country:
US
Number:
201662360245 PDate:
8.7.2016Country:
US
Classification
Categories:
A61K 35/00, A61K 35/17, A61K 35/28, A61K 38/00, C07H 21/04, C07K 14/725, C07K 14/705, C07K 14/715, C12N 9/22, C12N 9/96, C12N 15/87, C12N 15/90, C07K 14/47, C12N 5/0783, C12N 15/113